Key result
Combining HOTAIR knockdown and fenofibrate inhibits glioma cell proliferation and invasion in preclinical models.
Why the study?
Fenofibrate-induced PPARα activation plays an important role in glioma progression, but the underlying mechanisms are poorly understood.
The combination of fenofibrate and HOTAIR knockdown inhibits glioma progression in preclinical models, suggesting a potential novel therapeutic approach.
Answers are grounded in this paper and cite their sources.
Should not change glioma practice; hypothesis-generating for fenofibrate plus HOTAIR targeting in humans.
BACKGROUND: Fenofibrate is a fibric acid derivative known to have a lipid-lowering effect. Although fenofibrate-induced peroxisome proliferator-activated receptor alpha (PPARα) transcription activation has been shown to play an important role in the malignant progression of gliomas, the underlying mechanisms are poorly understood. METHODS: In this study, we analyzed TCGA database and found that there was a significant negative correlation between the long noncoding RNA (lncRNA) HOTAIR and PPARα. Then, we explored the molecular mechanism by which lncRNA HOTAIR regulates PPARα in cell lines in vitro and in a nude mouse glioma model in vivo and explored the effect of the combined application of HOTAIR knockdown and fenofibrate treatment on glioma invasion. RESULTS: For the first time, it was shown that after knockdown of the expression of HOTAIR in gliomas, the expression of PPARα was significantly upregulated, and the invasion and proliferation ability of gliomas were obviously inhibited. Then, glioma cells were treated with both the PPARα agonist fenofibrate and si-HOTAIR, and the results showed that the proliferation and invasion of glioma cells were significantly inhibited. CONCLUSIONS: Our results suggest that HOTAIR can negatively regulate the expression of PPARα and that the combination of fenofibrate and si-HOTAIR treatment can significantly inhibit the progression of gliomas. This introduces new ideas for the treatment of gliomas.
No takes yet. Share an insight, caveat, or question.
Zhu et al. (2021) studied Glioma (n=702). Fenofibrate and si-HOTAIR vs. Control was evaluated on Glioma cell proliferation and invasion (p=<0.05). The combination of HOTAIR knockdown and fenofibrate treatment significantly inhibited the proliferation and invasion of glioma cells both in vitro and in a mouse xenograft model.
Synapse has enriched 10 related papers. Consider them for comparative context: